Nab-paclitaxel in pretreated metastatic breast cancer: evaluation of activity, safety, and quality of life

OBJECTIVE: Metastatic breast cancer (MBC) is an incurable disease; the treatment of this disease prolongs survival, improving the quality of life (QoL) with a balance between efficacy and toxicity of the treatment. In recent years, treatment with nab-paclitaxel has improved the already known antitum...

Descripción completa

Detalles Bibliográficos
Autores principales: De Luca, Rossella, Profita, Giuseppe, Cicero, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396668/
https://www.ncbi.nlm.nih.gov/pubmed/30881017
http://dx.doi.org/10.2147/OTT.S191519

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396668/
https://www.ncbi.nlm.nih.gov/pubmed/30881017
http://dx.doi.org/10.2147/OTT.S191519

Ejemplares similares